C0073371||rifamycin SV
C0005149||β2-microglobulin
C3850147||aggregation
C3266969||Dialysis-related
C0002726||amyloidosis
C0002726||Dialysis-related amyloidosis
C1456454||amyloidogenic
C0005149||β2-microglobulin (β2m) protein
C0521324||skeletal
C0005149||β2m
C3850147||aggregation
C3494273||molecular docking
C0003232||antibiotic
C0073371||rifamycin SV
C0073371||C1
C0005149||β2m
C3494273||molecular docking analysis
C0073371||C1
C0678607||hydrophobic contacts
C3850147||aggregation
C0005149||β2m
C0005149||β2m
C0073371||C1
C0073371||C1
C0301641||conformational transition
C1707271||C-terminal region
C0005149||β2m
C0162806||β-sheet
C0033625||conformation
C3544412||fibrillogenesis
C0005149||β2m
C0005149||β2m
C3850147||aggregation
C0243077||inhibitors
C0005149||β2m